← Back to Search

CARE Model Therapy for Stuttering

N/A
Recruiting
Led By Courtney T Byrd, PhD
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 11-weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing online therapy sessions and specialized training for speech therapists to help people who stutter. It focuses on both monolingual and multilingual speakers. The goal is to improve their speech fluency by addressing various factors like speech patterns, language skills, and psychological aspects.

Who is the study for?
This trial is for children (2-17 years) and adults (18+ years) who stutter. Eligible participants are those recognized by caregivers or self-reported as individuals who stutter, have been diagnosed by a speech-language pathologist, or show a certain level of disfluency in their speech.
What is being tested?
The study is examining the Blank Center CARE Model(TM), focusing on how it can help people who stutter. It looks at contributions to stuttering and evaluates telehealth treatments and training methods for fluency disorders.
What are the potential side effects?
Since this trial involves non-medical interventions like speech therapy, there aren't typical medical side effects; however, participants may experience fatigue or frustration during treatment sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~11-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 11-weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Advocacy
Communication Competence
Education
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Blank Center CARE Model (Communication, Advocacy, Resilience, Education)Experimental Treatment1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for stuttering, particularly those involving speech-language pathology and telehealth, focus on improving fluency by addressing speech, language, and psychosocial factors. These treatments often include techniques such as controlled fluency shaping, which helps patients develop smoother speech patterns, and stuttering modification, which aims to reduce the severity and frequency of stuttering episodes. Additionally, cognitive-behavioral therapy (CBT) is used to address the anxiety and negative emotions associated with stuttering. The use of telehealth allows for greater accessibility and consistency in treatment, which is crucial for sustained improvement. These mechanisms are important for stuttering patients as they not only improve speech fluency but also enhance overall communication skills and reduce the psychological burden of stuttering.

Find a Location

Who is running the clinical trial?

University of Texas at AustinLead Sponsor
378 Previous Clinical Trials
83,609 Total Patients Enrolled
Courtney T Byrd, PhDPrincipal InvestigatorThe University of Texas at Austin

Media Library

The Blank Center CARE Model(TM) for Individuals who Stutter Clinical Trial Eligibility Overview. Trial Name: NCT05908123 — N/A
Stuttering Research Study Groups: Blank Center CARE Model (Communication, Advocacy, Resilience, Education)
Stuttering Clinical Trial 2023: The Blank Center CARE Model(TM) for Individuals who Stutter Highlights & Side Effects. Trial Name: NCT05908123 — N/A
The Blank Center CARE Model(TM) for Individuals who Stutter 2023 Treatment Timeline for Medical Study. Trial Name: NCT05908123 — N/A
~1550 spots leftby May 2035